Crimson Publishers Publish With Us Reprints e-Books Video articles

Full Text

Research in Pediatrics & Neonatology

Hypertension Since Birth (or Neonatal Period) to Adulthood

Maria Agostina Grillo1,2* and Jorge R Ferraris1,2*

1Pediatric Department Hospital Italiano de Buenos Aires, Argentina

2Pediatric Nephrology Service, Universidad de Buenos Aires, Argentina

*Corresponding author: Maria Agostina Grillo and Jorge R Ferraris, Pediatric Department Hospital Italiano de Buenos Aires, Pediatric Nephrology Service, Universidad de Buenos Aires, Argentina

Submission: May 20, 2024; Published: June 10, 2024

DOI: 10.31031/rpn.2024.08.000687

ISSN: 2577-9200
Volume8 Issue3

Abstract

Preterm newborns and small for gestational age (SGA) are particularly vulnerable to the development of hypertension (HTN) and chronic kidney disease (CKD). Fetal programming of HTN occurs in response to an insult during intrauterine life, which leads to adaptations by the fetus to allow fetal survival, but also results in permanent structural and physiological changes with long-term consequences such as an increased risk for cardiovascular disease and HTN. The mechanisms involved are: Renal alterations, vascular dysfunction, oxidative stress and epigenetic changes. Diagnosis and treatment of neonatal HTN remain challenging, with global incidence from 0.2%-3%, and there are a multitude of causes of neonatal hypertension. Most prematurity-related neonatal HTN resolves but the compensation mechanisms responsible may leave them at risk of later cardiovascular and kidney disease, in later childhood or adulthood, with a prevalence of HTN in children/adolescents born preterm up to 25%, diagnosed with both health check and ambulatory blood pressure monitoring. In adulthood gestational age is inversely associated with ischemic heart disease risk. They could present altered cardiac shape characterized by increased right and left ventricular mass, reduced right and left ventricle lengths, and smaller internal cavity diameters. Up to 10% of the population are preterm individuals, so we are facing a “silent epidemic” of CKD and HTN in these patients; preventive strategies should be implemented early to avoid the progression of these and CVD.

Keywords: Preterm neonates; Low birth weight; Arterial hypertension; Fetal programming; Small for gestational age; Cardiovascular disease

Introduction

Preterm birth (those born before 37 weeks gestational age) affects ∼11% of births worldwide, similar to an annual prevalence of prematurity in Argentina between 8 and 9%, with the survival of infants born at 22 or 23 weeks with birth weights close to 500gr thanks to the new therapeutics and the increasing complexity of neonatal intensive care units [1-3].

Preterm newborns and small for gestational age (SGA) (birth weight of less than 10th percentile for gestational age) are particularly vulnerable to the development of hypertension (HTN) and chronic kidney disease (CKD). In the former, there is premature exposure to the conditions of extrauterine life, in organs that are not yet prepared for it, where the premature arrest of the development of the vascular tree results in stiffer and narrower arteries, which predisposes to glomerular and endothelial damage, structural alterations due to glomerular hyperfiltration, and increased systolic blood pressure (SBP) in children and adults [3,4]. SGA infants may be at increased risk of higher BP later in life, which may be in part due to a decreased nephron development as well as other factors, such as exposure to intrauterine stress that generates an altered fetal programming, placental insufficiency, or altered vascular system.

Although the morbidity and the complications of the appearance of arterial HTN in the neonatal period has not been completed established, it could be a predisposing factor for the appearance of cardiovascular and renal disease in the long term, hence this is an important disease that needs to be recognized and addressed prior to Neonatal intensive unit care discharge.

We consider that we are facing a “silent epidemic” of CKD and HTN in these patients, so preventive strategies should be implemented early to avoid the progression of these and CVD.

Pathophysiology

There are few mechanisms linking impaired fetal growth and the increased risk of CVD and HTN in adulthood.

Fetal programming of HTN occurs in response to an insult during intrauterine life, which leads to adaptations by the fetus to allow fetal survival, but also results in permanent structural and physiological changes with long-term consequences such as an increased risk for CVD and HTN [5,6]. The intensity, timing and nature of the fetal insult are critical to the phenotypic outcome.

The renal alterations that have been reported in fetal programming of HTN include small kidney size at birth (reduced nephron number), kidney disfunction, and alterations in sodium transport, renin-angiotensin aldosterone system (RAAS), and sympathetic renal nerves.

In subjects preterm or low birth weight has been demonstrated a lower nephron number with a smaller glomerular filtration area, causing compensatory glomerular hyperfiltration and hypertrophy, and eventually glomerulosclerosis with kidney injury favoring the development of HTN [3,5-7]. Alterations in the RAS appear to contribute to hypertension programmed in response to certain fetal insults, with different impact and with tissue specific effects [6]. For example, in one animal model, late gestational exposure to glucocorticoids leads to an increase in fetal pulmonary angiotensin converting enzyme (ACE) expression associated with an increase in blood pressure [8]. On the contrary, another experimental animal study (sheep) shows that placental insufficiency leads to suppression of the fetal renal RAS, and this could alter the activity of the intrarenal RAS and so affect growth and development of the kidney [9].

Another mechanism involved in the fetal programming of hypertension is vascular dysfunction. Fetal stress may affect vasculo-genesis and cause vascular remodeling. This process is characterized by changes such as an alteration in wall thickness and lumen diameter, which may develop or be precursors of HTN later in life. In the case of intrauterine growth restriction, elastin synthesis is altered during the fetal stage, reducing arterial elasticity [10,11]. Preterm birth results in a restricted vascular bed, impaired endothelial function, narrowed and stiffer arteries, predisposing to endothelial dysfunction and arterial hypertension.

On the other hand, it has been proposed that oxidative stress produced by vascular, immune, and enzyme systems may account for several organ system alterations, such as endothelial dysfunction with increased vascular tone. Maternal deprivation, sodium overload during pregnancy, and placental dysfunction are associated with higher oxygen radicals being one of the plausible mediators between adverse fetal growth and higher risk for CVD and HTN [6,12,13].

In addition, studies suggest that epigenetic changes are one of the mechanisms responsible for fetal programming that may explain both organ system alterations and vascular dysfunction and HTN in the offspring. These epigenetic changes consist in modifications in genes related to the RAAS, angiotensin type 1 receptor, vascular tone, ion channels, epithelial sodium channels, Na+-K+-2Cl- cotransporter, an increased expression of micro-RNA that regulates the translation of angiotensin converting enzyme-1, micro-RNA associated with cardiac injury, angiogenesis, and cell changes, modifications in endothelial nitric oxide synthase (eNOS), and DNA modifications in important genes in endocrine hypertension [5,14].

Neonatal hypertension

Diagnosis and treatment of neonatal HTN remain challenging, due to the scarcity of normative data on neonatal blood pressure values, the relative rarity of the condition, and exclusion of neonates from clinical trials of antihypertensive medications [15]. The global incidence ranges from 0.2%-3%, but these values may change according to population studied, being higher in preterm newborns who were in critical condition [16].

The gold standard for blood pressure measurement remains to be the invasive intra-arterial measurement; this is most commonly done in a NICU and measured with an umbilical artery catheter. However, the majority of umbilical arterial catheters are not placed to monitor for hypertension. In this population the method of choice is oscillometric devices, which have a good correlation between oscillometric and umbilical or radial artery BP, are easy to use and provide the ability to follow BP trends over time [17,18].

HTN is defined as systolic and/or diastolic BPs persistently equal to or greater than the 95th percentile according to the tables for gestational age and postmenstrual or postconceptional age [15,16,19]. Dionne [18], created tables which provide derived systolic and diastolic BP percentiles based on post-menstrual age [18] (Table 1).

Table 1:Blood pressure values at weeks gestational age in the newborn from 26 to 44 weeks SBP: systolic blood pressure; SBP: diastolic blood pressure; MAT: mean arterial pressure. Reproduced from Arterial hypertension in the newborn, Comité Nacional de Nefrología, Comité de Estudios Feto Neonatales (CEFEN), 2020, with authorization. Adapted from Dionne [18].


In term and preterm infants, blood pressure (BP) increases with gestational age and postmenstrual age, along with birth weight [15- 17], and in the first ones, the strongest predictor of BP appears to be postmenstrual age, with a rise in the first 3-7 days of age in both systolic and diastolic BPs that is considered normal [17].

In this sense, BP values change rapidly over the first days of life, especially in those born preterm [20]. Pejovic [21] in a prospective study found that in infants born <28 weeks, the mean BP increases by 26% in the first week and >50% over the first month of life. Also showed the most premature and lowest weight neonates having the lowest blood pressures at birth, however demonstrated the most rapid rate of increase in BP in the most premature infants [6,21]. For most term infants, BP increases significantly from the first to second day of life but less so on subsequent days [19], with a less marked rise in BP (by >20% over the first month of life) [20].

It is not entirely defined at what level birth weight influences or determines blood pressure. In one study of preterm infants, BP inversely correlated with birth weight in those born with SGA, especially in the first week of life; on the other hand, the infants born with an appropriate weight for gestational age had a positive correlation [3,22].

While intrauterine growth restriction (IUGR) (when a fetus does not achieve the expected in utero growth potential due to genetic or environmental factors, estimated fetal weight <10th percentile) is considered as a possible risk factor for kidney damage and high BP in later life, one recently study did not observe any significant differences in BP values and urinary protein/creatinine ratios between between IUGR and non-IUGR neonates and young infants [21].

The most common causes of neonatal hypertension are umbilical artery catheter-associated thromboembolism, kidney disease, and chronic lung disease [23]; however numerous other causes and coexisting conditions have been identified in infants with HTN: antenatal steroid exposure, maternal HTN, acute kidney injury, extracorporeal membrane oxygenation (ECMO) therapy, congenital or acquired renal disease, parenteral nutrition (volume, calcium and salt excess), coarctation of the aorta and disorders of the endocrine system [15-17,24-26]. Historically, the leading cause of hypertension has been renal abnormalities (polycystic kidney diseases) [17], however in up to 50% of cases of neonatal HTN, no cause is detected [16,17,27] (Table 2). Considering causes associated with renal abnormalities, the AWAKEN study has shown a significant association with acute kidney injury (AKI) and neonatal hypertension [28]. From 10% to 20% of newborns with AKI have hypertension, usually associated with hypervolemia, so treatment focuses on correcting fluid overload with furosemide if needed [29]. The diagnosis of AKI is mostly based on imperfect parameters including serum creatinine levels and urine output; in neonates obtaining accurate glomerular filtration rate (GFR) is challenging as SCR values has several drawbacks, at the beginning reflect maternal creatinine levels, is also cleared by tubular secretion and GFR increases in the first days of life [30]. Other endogenous or exogenous markers for GFR exist, but are rarely used in daily clinical care [30]. The evaluation with complementary studies to reach an etiological diagnosis can be guided by the tests proposed in Table 3.

Table 2:Causes of neonatal Hypertension (HTN).


Table 3:Complementary studies for neonatal hypertension DTPA: diethylenetriamine penta acetic acid; Mag-3: mercaptoacetyltriglycerine.


Raj Sahu et al., in a retrospective study showed that term infants were diagnosed with HTN significantly earlier, with higher incidence of resistant HTN, some requiring greater than 3 medications to control their blood pressure and shorter duration of stay than preterm infants. The major risk factors for preterm infants were bronchopulmonary dysplasia and iatrogenic factors (ex. chronic steroids), and in term infants they were cardiac and other systemic disease [26].

Treatment aimed at reducing the BP (objective below the 90th percentile) needs to be considered carefully, guided by the pediatric nephrologist. There are wide options of pharmacological treatments, however the literature on treatment of neonatal hypertension is limited [17].

For most neonates diagnosed with HTN, the long-term outcomes should be good, and HTN will resolve over time; one study indicates that most infants will be off medication by 6 months of age. Infants with HTN associated with bronchopulmonary dysplasia almost universally resolve by 2 years of age. However, long-term outcome studies of infants with neonatal HTN are needed [15,25].

Long-term monitoring of infants with neonatal HTN is essential, with periodic monitoring of BPs and renal function, at least until the HTN has resolved, it is unclear how long and what follow-up is required. Serial ultrasonography may be helpful to follow renal growth, or the evolution of renal parenchymal disease [15].

Hypertension in children and adolescents born preterm

Most prematurity-related neonatal hypertension resolves but the compensation mechanisms responsible for the improvement may leave them at risk of later cardiovascular and kidney disease [31].

Several publications highlight the relationship between fetal growth restriction, low birth weight, preterm delivery and elevated BP later in life [3,32].

One publication reported a prevalence of HTN in children and adolescents born preterm ranged from 6 to 25% [33,34].

Rodriguez [35] showed in children aged 1-7 years with a history of PTN and SGA, increased systolic BP (SBP) in 21% and diastolic BP (DBP) in 37% of patients, with mean SBP and DBP between 10 and 15mmHg above the mean of healthy term newborns. They have associated a decreased glomerular filtration rate (GFR) (78 ± 26.8ml/min/1.73m2) and Umicroalbuminuria/Ucreatininuria (85 ± 187 mg/gr) [35].

In the same line, Mhanna [36] evaluated 204 patients over 3 years of age, who had been born weighing <1,000g, with gestational age of 26 weeks; they found a prevalence of HTN of 7.3%, associated with an increase in the body mass index (BMI) and with higher weight gain from birth [36].

One prospective observational case-control study showed children born preterm at <30 weeks GA had higher systolic and diastolic BPs, and higher prevalence of elevated BP beyond the 90th, especially in those with lower GA and younger age at last follow up. Albumin and calcium excretion in the urine were similar in preterm-born children and term-born controls [33].

Andrea Solís [37] carried out a descriptive study to evaluate the prevalence of HTN by ambulatory blood pressure monitoring (ABPM) in patients aged 5-7 years who were premature <32 weeks gestational age and less than 1500 grams of birth weight. Although the sample size is small (19 patients) and no diagnosis of HTN was made, stands out the presence of pathological findings as absence of systolic and/or diastolic nocturnal dipping (47%) [37]. In the same way, Bayrakci [38] assessed BP patterns with ABPM and found preterm children and adolescents had similar 24-hour and daytime blood pressure but higher nighttime blood pressure and less nocturnal dipping than term controls [38].

In pediatric patients, there are no studies that show a direct relationship between the absence of nocturnal dipping and target organ damage, but it is proposed that the presence of an alteration in the normal variation of pressure during the day would be a risk factor for progression to HTA [39].

Another analysis made in adolescents of median 14-year-olds that were born PTN (mean 27.8 weeks) with very low birth weight (mean 1048grs) compared to term peers, showed the first ones had higher SBP and DBP (3.5mmHg, 95% CI − 0.1 to 7.2 and 3.6mmHg, 95% CI 0.1 to 7.0). The preterm birth cohort also had a significantly greater rate of high blood pressure; the differences in DBP was greater in individuals without overweight/obesity. The PTN group had significantly higher rates of maternal hypertensive pregnancy, maternal smoking and cesarean section. There were no differences in weight, BMI, or rates of overweight [40]. In adolescents born with PTN, albumin-to-creatinine ratio was modestly greater in subjects with overweight; this suggests that the development of obesity during adolescence may compound the risk of developing renal disease in these individuals [40].

Being born intrauterine growth-restricted or SGA has been associated with higher rates of HTN later in life [31]. In a prospective study evaluating children between the ages of 6-10 years born term but SGA compared to adequate GA (AGA), by ABPM measurements, 18% SGA had HTN while none of the children born AGA. Also, elevated BP was found in 50% of the SGA children compared to only 16% in those born AGA and a significantly higher blood pressure load (systolic and diastolic) was found in the SGA patients [41]. In part, these differences could be attributed to vascular alterations in those born with SGA, that show more arterial stiffness and endothelial dysfunction [31]. However, other studies suggest that SGA children had significantly lower BP values than AGA, so it is difficult to clearly assess the impact of IUGR in preterm babies on BP values in future life [34].

The most frequently targeted organs damaged in childhood due to hypertension are the heart (left ventricular hypertrophy) and blood vessels such as the coronary, the cerebral and the kidney vessels.

In another study, one-third of children who had AKI during the neonatal period had at least one sign of long term kidney dysfunction (hypertension, proteinuria or hyperfiltration); the ones who had a worse stage of AKI tended to have a higher rate of ABPM hypertension, non-dipper patron or another abnormal ABPM results, although the differences did not reach statistical significance [42]. In this group, ABPM hypertension was more frequent in patients with a gestational age <32 weeks and birth weight <1,500g.

As a consequence of low nephron endowment, prematurity is associated with chronic kidney disease. Emerging evidence suggests that perinatal characteristics could be indicators of future risk of transplant [43]. One Canadian cohort investigated the degree to which maternal and neonatal complications of pregnancy were associated with the likelihood of requiring an organ or tissue transplant before 14 y of age. Preterm birth was associated with 6.30 times the risk of kidney transplant (95% CI, 3.23-12.31), compared with term birth, especially in children with urinary anomalies [43]. Other perinatal factors associated were neonatal sepsis, intubation, blood transfusion, oligohydramnios, and congenital anomalies.

Hypertension in adults

Impaired fetal growth is associated with CVD in adulthood [44]. IUGR and preterm birth are both risk factors for the development of adult HTN, and IUGR or SGA are considered more associated with higher rates of HTN than prematurity alone [31,45], secondary to previously described renal and vascular compromise. This association both with prematurity and IUGR starts in early childhood and could become augmented in adulthood, at which stage blood pressures typically reach hypertensive ranges [46].

A meta-analysis including preterm-born adults concluded that the mean difference between preterm-born adults and controls was 4.2mmHg for SBP and 2.6mmHg for DBP. In another metaanalysis of 1,571 adults born with very low birth weight (defined according birth weight < 1,500g) vs. 777 full-term controls, mean blood pressure averages were higher for subjects <1,500g; they had 3.4mmHg higher SBP and 2.1mmHg higher DBP than controls. The only perinatal event associated with higher BP was maternal preeclampsia [3,47].

Along the same lines, in another study that included subjects born < 35 weeks and/or a birth weight below 2,000gr, birth weight was negatively associated with HTN, with the incidence being higher with smaller fetal size [48].

Brewer P [49] evaluated a group of women aged 50 to 79 years, self-reported being born preterm. Preterm status was statistically significant associated with prevalent HTN (37% vs 33.1%), early-onset HTN (<50 years), and taking more antihypertensive medications. Women born preterm without actual HTN had elevated coronary heart disease compared with women born fullterm [49].

In a Swedish study cohort with median age 22.5 years, they showed that across all attained ages (0-43 years), gestational age at birth was inversely associated with HTN risk and each additional week of gestation was associated with a 4% lower risk of HTN. Persons born extremely premature had a 1.8-fold risk of HTN, and also have a major risk of ischaemic heart disease, heart failure, and cerebrovascular disease. The highest risk of HTN was observed among those exposed to both preterm birth and preeclampsia [50].

Different studies consistently show a dose-response relationship between degree of prematurity and increase in BP; with higher resting systolic BP in the range of 3.8-4.6mm Hg in individuals born preterm and an increase in diastolic BP of 2.6mm Hg which are clinically important differences in cardiovascular risk (stroke mortality and mortality from other vascular diseases) [51].

These findings suggest that infants who are born preterm have modestly elevated BP at young adulthood, but are susceptible to develop HTN with associated other cardiovascular and renal complications [52]. Several studies have demonstrated a link between low birth weight and Chronic Kidney Disease (CKD) [52]. In a meta-analysis low birth weight was associated with CKD with an overall odds ratio (OR) of 1.73 [52,53]. Superimposed SGA seems to increase the risk of cardiovascular and renal diseases [52].

ABPM also reveals higher 24-h BP in 114 preterm- and compared to 103 term-born young adults, showing higher 24-hour and awake systolic and diastolic BP, and higher sleep systolic BP in preterm birth below 34 weeks [54].

Impact of preterm heart

Preterm-born individuals are at greater risk of all-cause mortality in young adulthood, as well as cardiometabolic diseases, including type 1 and 2 diabetes mellitus, ischemic heart disease, HTN, pulmonary vascular disease and increased risk of heart failure [10].

Carr [55], published a study with the incidence rates of heart failure that were inversely related to gestational age at birth, with a 17-fold increased risk in those born extremely preterm compared with those born at term [55].

Crump et al in a Sweden cohort investigated the association between prematurity and increased risk of ischemic heart disease in adulthood. Gestational age was inversely associated with ischemic heart disease risk. Both preterm birth and earlyterm birth were associated with increased relative risks of ischemic heart disease (53% and 19%, respectively) [56].

One explanation for this is that the most premature individuals (<28 weeks’ gestation) may have the lowest cardiac endowment and thus the fewest overall number of cardiomyocytes and lower cardiac mass [10]. This individual could have impairments in both left and right ventricular myocardial functional reserve, which is likely to increase susceptibility to heart failure later in life, particularly with additional insults such as hypertension or myocardial infarction [10]. Preterm-born young adults present altered cardiac shape characterized by increased right and left ventricular mass, reduced right and left ventricle lengths, and smaller internal cavity diameters for both ventricles. These alterations were independent of elevations in BP and were proportional to the degree of prematurity [51].

Another study investigated the cardiac impact of being born preterm in young adulthood using cardiovascular magnetic resonance in 234 individuals, of whom 102 were born preterm with an average gestational age of 30 weeks. Of them, 14 pretermborn individuals had smaller left ventricular (LV) end-diastolic volumes, smaller internal LV cavity dimensions and lengths, as well as greater LV wall thickness and mass [57].

In the perinatal period, especially in UCIN, some interventions and complications including infection, accelerated postnatal weight gain, parenteral nutrition, and antenatal and postnatal steroids, have been shown to relate to increased vascular stiffness and may contribute to long term cardiovascular remodeling. However, further work is needed to determine the long-term effects of these early life interventions [10].

In the same line, one systematic review [58] indicates that premature birth during the past 50 years is associated with modestly increased mortality in early to mid-adulthood. Gestational age at birth was inversely associated with all major causes of death including respiratory, cardiovascular, endocrine (mostly diabetes), neurological, cancer, and external causes, across ages 0-45 years. In late adulthood there is a strong association with endocrine and respiratory mortality [58,59].

In one study with the longest follow-up, up to a maximum age of 86 years but born in earlier years (1915-1929), reported that gestational age at birth was inversely associated with risk of death from cerebrovascular disease and occlusive stroke, but not with ischemic heart disease or all-cause mortality [60].

There is limited data to suggest specific pharmacological therapeutic strategies in adults born preterm to treat HTN or modify heart failure risk. Considering that these diseases could be generated by elevated plasma levels of angiotensin I, low glomerular endowment with glomerular hyperfiltration, autonomic dysfunction and impaired heart rate recovery, could exist a potential role for angiotensin or adrenergic blockade, but these have not been specifically evaluated in preterm subjects.

Impact of maternal disorder

Maternal hypertensive disorders of pregnancy (preeclampsia or eclampsia, gestational hypertension, and pregestational hypertension) are associated with an increased risk of congenital heart disease and a number of risk factors of CVD in offspring, with a Denmark study reporting individuals born to mothers with these disorders had a 23% increased risk of early onset CVD, especially of those mothers with a history of CVD or diabetes [61]. They also showed severity of preeclampsia influenced the association, being the strongest association for early-onset and severe preeclampsia [61]. In individuals born at term also severe preeclampsia was found to be an independent risk factor for cardiovascular morbidity [62]. A systematic review evidenced in utero exposure to preeclampsia was associated with higher systolic and diastolic blood pressure and higher BMI during childhood and young adulthood; there was no evidence of variation in lipid profile or glucose metabolism [62].

Conclusion

Preterm birth and being small for gestational age should be considered as a (new) risk factors for the development of arterial hypertension and cardiovascular morbidities, both in childhood (sometimes reversible) and in adulthood, associated with modestly increased mortality risks in early to mid-adulthood, considering likewise that fortunately most people who were born preterm survive into adulthood without major comorbidities.

For this, preterm birth should be recognized as a chronic condition and assessed as a CVD risk factor that requires long-term follow-up for preventive actions, monitoring, and treatment of potential health sequelae across the life course.

Preventive strategies involve efforts to improve global maternal gestational health and nutrition, prevent preterm birth and SGA, avoid repeated courses of antenatal steroids, promote maternal milk as first-line nutrition, avoid extra uterine growth restriction and avoid overgrowth after hospital discharge, limit exposure to nephrotoxic drugs from neonatal to adulthood, and to promote a healthy lifestyle including regular physical activity, avoid smoking, and overweight.

Statements and Declarations

Authors contribution

MG and JF: concept and design and drafting of the manuscript. MG and JF: acquisitions, analysis, and interpretation of data. JF: critical revision of the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Alda E, Sebastiani M, Otaño L, Apas A, Corimayo L, et al. (2014) Recommendations for the management of pregnancy and the newborn at the limits of viability. Neonatology Area. National Directorate of Maternity and Childhood. Ministry of Health, Presidency of the Argentine Nation.
  2. (2018) Statistical Synthesis No. 6 DEIS. Birth and Mortality. Argentine Ministry of Health.
  3. Grillo MA, Mariani G, Ferraris JR (2022) Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age. Front Med 8: 769734.
  4. Sutherland MR, Bertagnolli M, Lukaszewski MA, Huyard F, Yzydorczyk C, et al. (2014) Preterm birth and hypertension risk: The oxidative stress paradigm. Hypertension 63(1): 12-18.
  5. Iturzaeta A, Sáenz TMM (2022) Early programming of hypertension. Arch Argent Pediatr 120(1): e8-e16.
  6. Ojeda NB, Grigore D, Alexander BT (2008) Role of fetal programming in the development of hypertension. Future Cardiol 4(2): 163-174.
  7. Luyckx VA, Bertram JF, Brenner BM, Caroline F, Wendy EH, et al. (2013) Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382(9888): 273-283.
  8. Zimmermann H, Gardner DS, Jellyman JK, Fowden AL, Giussani DA, et al. (2003) Effect of dexamethasone on pulmonary and renal angiotensin-converting enzyme concentration in fetal sheep during late gestation. Am J Obstet Gynecol 189(5): 1467-1471.
  9. Zhang DY, Lumbers ER, Simonetta G, Wu JJ, Owens JA, et al. (2000) Effects of placental insufficiency on the ovine fetal renin-angiotensin system. Exp Physiol 85(1): 79-84.
  10. Lewandowski AJ, Levy PT, Bates ML, McNamara PJ, Nuyt AM, et al. (2020) Impact of the vulnerable preterm heart and circulation on adult cardiovascular disease risk. Hypertension 76(4): 1028-1037.
  11. Martin H, Hu J, Gennser G, Norman M (2000) Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation 102(22): 2739-2744.
  12. Schnackenberg CG (2002) Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol 2(2): 121-125.
  13. Franco MC, Dantas AP, Akamine EH, Elisa MK, Zuleica BF, et al. (2002) Enhanced oxidative stress as a potential mechanism underlying the programming of hypertension in utero. J Cardiovasc Pharmacol 40(4): 501-509.
  14. Guarner LV, Ramírez HA, Rubio RME, Castrejón TV, Soto ME, et al. (2020) Early programming of adult systemic essential hypertension. Int J Mol Sci 21(4): 1203.
  15. Starr MC, Flynn JT (2019) Neonatal hypertension: Cases, causes, and clinical approach. Pediatr Nephrol 34(5): 787-799.
  16. (2020) National committee on nephrology, Committee for Feto-neonatal Studies (CEFEN). High blood pressure in the newborn. Arch Argent Pediatr 118(6): S153-S163.
  17. Harer MW, Kent AL (2019) Neonatal hypertension: An educational review. Pediatr Nephrol 34(6): 1009-1018.
  18. Dionne JM, Abitbol CL, Flynn JT (2012) Hypertension in infancy: Diagnosis, management and outcome. Pediatr Nephrol 27(1): 17-32.
  19. Kent AL, Kecskes Z, Shadbolt B, Falk MC (2007) Blood pressure in the first year of life in healthy infants born at term. Pediatr Nephrol 22(10): 1743-1749.
  20. Flynn JT (2020) The hypertensive neonate. Semin Fetal Neonatal Med 25(5): 101138.
  21. Pejovic B, Peco AA, Marinkovic EJ (2007) Blood pressure in non-critically ill preterm and full-term neonates. Pediatr Nephrol 22(2): 249-257.
  22. Heuchel KM, Ebach F, Alsat EA, Reutter H, Mueller A, et al. (2022) Blood pressure and kidney function in neonates and young infants with intrauterine growth restriction. Pediatr Nephrol 38(4): 1223-1232.
  23. Smal JC, Uiterwaal CS, Bruinse HW, Steendijk P, Van BF (2009) Inverse relationship between birth weight and blood pressure in growth-retarded but not in appropriate for gestational age infants during the first week of life. Neonatology 96(2): 86-92.
  24. Joseph TF (2021) Etiology, clinical features, and diagnosis of neonatal hypertension.
  25. Seliem WA, Falk MC, Shadbolt B, Kent AL (2007) Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol 22(12): 2081-2087.
  26. Sahu R, Pannu H, Yu R, Shete S, Bricker JT, et al. (2013) Systemic hypertension requiring treatment in the neonatal intensive care unit. J Pediatr 163(1): 84-88.
  27. Jenkins RD, Aziz JK, Gievers LL, Mooers HM, Fino N, et al. (2017) Characteristics of hypertension in premature infants with and without chronic lung disease: A long-term multi-center study. Pediatr Nephrol 32(11): 2115-2124.
  28. Kraut EJ, Boohaker LJ, Askenazi DJ, Fletcher J, Kent AL, et al. (2018) Incidence of neonatal hypertension from a large multicenter study [Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates-AWAKEN]. Pediatr Res 84(2): 279-289.
  29. (2020) National committee on nephrology. Consensus of acute kidney injury in the newborn. Arch Argent Pediatr 118(1): S50-S58.
  30. Smeets NJL, Teunissen EMM, Van der VK, Maurice JPVB, Demi EL, et al. (2023) Glomerular filtration rate in critically ill neonates and children: Creatinine-based estimations versus iohexol-based measurements. Pediatr Nephrol 38(4): 1087-1097.
  31. Altemose K, Dionne JM (2022) Neonatal hypertension: Concerns within and beyond the neonatal intensive care unit. Clin Exp Pediatr 65(8): 367-376.
  32. Zanchetti A (2016) From pregnancy to childhood and adulthood: The trajectory of hypertension. J Hypertens 34(7): 1235-1236.
  33. Vashishta N, Surapaneni V, Chawla S, Kapur G, Natarajan G (2017) Association among prematurity (<30 weeks' gestational age), blood pressure, urinary albumin, calcium, and phosphate in early childhood. Pediatr Nephrol 32(7): 1243-1250.
  34. Poplawska K, Dudek K, Koziarz M, Cieniawski D, Drożdż T, et al. (2012) Prematurity-related hypertension in children and adolescents. Int J Pediatr 2012: 537936.
  35. Rodríguez LI, Miceli SC, D'Urso VM, Maurizi M, Caram ME, et al. (2021) Renal size, blood pressure, microalbuminuria and glomerular filtration rate are advisable to monitor in the follow-up of infants born prematurely. Journal of Nephrology, Dialysis and Transplantation 41: 9-22.
  36. Mhanna MJ, Iqbal AM, Kaelber DC (2015) Weight gain and hypertension at three years of age and older in extremely low birth weight infants. J Neonatal-Perinatal Med 8(4): 363-369.
  37. Solís A, Cerda J, González C (2018) Ambulatory blood pressure monitoring in school children with a history of extreme prematurity. Chilean Journal of Pediatrics 89(1): 18-23.
  38. Bayrakci US, Schaefer F, Duzova A, Yigit S, Bakkaloglu A (2007) Abnormal circadian blood pressure regulation in children born preterm. J Pediatr 151(4): 399-403.
  39. Palatini P, Reboldi G, Beilin LJ, Edoardo C, Kazuo E, et al. (2014) Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: The ambulatory blood pressure-international study. Hypertension 64(3): 487-493.
  40. South AM, Nixon PA, Chappell MC, Debra ID, Gregory BR, et al. (2019) Renal function and blood pressure are altered in adolescents born preterm. Pediatr Nephrol 34(1): 137-144.
  41. Zamecznik A, Niewiadomska JK, Wosiak A, Zamojska J, Moll J, et al. (2014) Intra-uterine growth restriction as a risk factor for hypertension in children six to 10 years old. Cardiovasc J Afr 25(2): 73-77.
  42. Akkoc G, Duzova A, Korkmaz A, Oguz B, Yigit S, et al. (2022) Long-term follow-up of patients after acute kidney injury in the neonatal period: Abnormal ambulatory blood pressure findings. BMC Nephrol 23(1): 116.
  43. Côté CG, Luu TM, Bilodeau BM, Auger N (2023) Association of maternal and neonatal birth outcomes with subsequent pediatric transplants. Transplantation 107(3): 720-728.
  44. Skilton MR, Viikari JS, Juonala M, Tomi L, Terho L, et al. (2011) Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 31(12): 2975-2981.
  45. Cho MH (2022) Hypertension in adulthood is programmed during the perinatal period. Clin Exp Pediatr 65(10): 494-495.
  46. Hovi P, Vohr B, Ment LR, Doyle LW, McGarvey L, et al. (2016) Blood pressure in young adults born at very low birth weight: Adults born preterm international collaboration. Hypertension 68(4): 880-887.
  47. Bonamy AK, Norman M, Kaijser M (2008) Being born too small, too early, or both: Does it matter for risk of hypertension in the elderly? Am J Hypertens 21(10): 1107-1110.
  48. Brewer PL, D'Agata AL, Roberts MB, Robert AW, Aladdin HS, et al. (2023) Association of preterm birth with prevalent and incident hypertension, early-onset hypertension, and cardiovascular disease in the women's health initiative. Am J Cardiol 192: 132-138.
  49. Crump C, Sundquist J, Sundquist K (2020) Risk of hypertension into adulthood in persons born prematurely: A national cohort study. Eur Heart J 41(16): 1542-1550.
  50. Bertagnolli M, Luu TM, Lewandowski AJ, Leeson P, Nuyt AM (2016) Preterm birth and hypertension: Is there a link? Curr Hypertens Rep 18(4): 28.
  51. Chehade H, Simeoni U, Guignard JP, Boubred F (2018) Preterm birth: Long term cardiovascular and renal consequences. Curr Pediatr Rev 14(4): 219-226.
  52. White SL, Perkovic V, Cass A, Choon LC, Neil RP, et al. (2009) Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis 54(2): 248-261.
  53. Sipola LM, Karvonen R, Tikanmäki M, Matinolli HM, Martikainen S, et al. (2015) Ambulatory blood pressure and its variability in adults born preterm. Hypertension 65(3): 615-621.
  54. Carr H, Cnattingius S, Granath F, Ludvigsson JF, Edstedt BAK (2017) Preterm birth and risk of heart failure up to early adulthood. J Am Coll Cardiol 69(21): 2634-2642.
  55. Crump C, Howell EA, Stroustrup A, McLaughlin MA, Sundquist J, et al. (2019) Association of preterm birth with risk of ischemic heart disease in adulthood. JAMA Pediatr 173(8): 736-743.
  56. Lewandowski AJ, Augustine D, Lamata P, Davis EF, Lazdam M, et al. (2013) Preterm heart in adult life: Cardiovascular magnetic resonance reveals distinct differences in left ventricular mass, geometry, and function. Circulation 127(2): 197-206.
  57. Crump C (2020) Preterm birth and mortality in adulthood: A systematic review. J Perinatol 40(6): 833-843.
  58. Blencowe H, Cousens S, Chou D, Mikkel O, Lale S, et al. (2013) Born too soon: The global epidemiology of 15 million preterm births. Reprod Health 10 Suppl 1(Suppl 1): S2.
  59. Juárez S, Goodman A, De Stavola B, Koupil I (2016) Birth characteristics and all-cause mortality: A sibling analysis using the Uppsala birth cohort multigenerational study. J Dev Orig Health Dis 7(4): 374-383.
  60. Huang C, Li J, Qin G, Zeyan L, Jing H, et al. (2021) Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study. PLoS Med 18(9): e1003805.
  61. Nahum SK, Friger M, Shoham VI, Efrat S, Ruslan S, et al. (2018) Prenatal exposure to preeclampsia as an independent risk factor for long-term cardiovascular morbidity of the offspring. Pregnancy Hypertens 13: 181-186.
  62. Davis EF, Lazdam M, Lewandowski AJ, Stephanie AW, Brenda K, et al. (2012) Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: A systematic review. Pediatrics 129(6): e1552-e1561.

© 2024 Maria Agostina Grillo and Jorge R Ferraris. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and build upon your work non-commercially.

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 260 Madison Ave, 8th Floor
  •     New York, NY 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com